Neela Therapeutics
PrivateLast Round
Seed Round
May 26, 2026
Total Funding Raised
$12.01M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neela Therapeutics is a biotechnology company that develops precision therapies for pediatric patients with rare and serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neela Therapeutics Comparables
Compare Neela Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tern Therapeutics | 83% | |
| Lysogene | 77% | |
| Taysha Gene Therapies | 75% |
Neela Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 26, 2026 | ||||
| VC Round | Nov 24, 2025 | ||||
| Convertible Debt | Nov 24, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2026
Raised $14M in a new seed funding round.
- Nov 24, 2025
$14M raised in a VC Round.
Neela Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access